Biotechnology - Will It Create a New Industry?

04/26/2002 3:00P 4-370
Henri A. Termeer, President and CEO, Genzyme Corporation

Description: This lecture is introduced by MIT Provost and Professor of Chemical Engineering Bob Brown, and recent Draper prize winner and Professor Robert S. Langer.

Henri Termeer discusses growth of the 25-year-old biotech industry, including international mergers, R&D challenges and "product based" companies verses "platform based" companies.


About the Speaker(s): Henri A. Termeer was appointed president of the Genzyme Corporation in 1983 and became the chief executive officer in 1985 and chairman in 1988. Under his leadership, Genzyme has grown from a modest entrepreneurial venture into one of the world's top five biotechnology companies. Mr. Termeer is known worldwide for his contributions to the biotechnology industry and particularly noted for his expertise in financing new initiatives. His innovative approaches have earned Genzyme the Laguna Niguel Best of Biotech Award in 1991 and 1994, as well as the Laguna Niguel Hall of Fame Award in 1997.

Prior to joining Genzyme, Mr. Termeer held various management positions over a 10-year period at Baxter Travenol (now Baxter International), including executive vice president of Baxter's Hyland Therapeutics Division and general manager of Travenol GmbH in Germany. In 1973, Mr. Termeer earned an MBA from the Darden School at the University of Virginia. A native of the Netherlands, he studied economics at the University of Rotterdam and speaks fluent Dutch, German, and English.

Host(s): School of Engineering, Department of Chemical Engineering

Tape #: T11441

credit

MIT World -- special events and lectures

license

MIT TechTV